TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
NCT03306199
·
clinicaltrials.gov ↗
COMPLETED
Status
82
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Arterial Disease
Interventions
DEVICE:
Laser Atherectomy
Sponsor
Spectranetics Corporation